[Rituximab in the treatment of indolent non-Hodgkin's lymphoma].
Aurer I, Mitrović Z, Radman I, Kovacević-Metelko J, Nemet D, Serventi-Seiwerth R, Stern-Padovan R, Jakic-Razumović J, Nola M, Zupancić-Salek S, Sertić D, Labar B.
Aurer I, et al. Among authors: sertic d.
Lijec Vjesn. 2004 Nov-Dec;126(11-12):307-11.
Lijec Vjesn. 2004.
PMID: 16082888
Clinical Trial.
Croatian.